Company Interpace Biosciences, Inc. Other OTC
Equities
IDXG
US46062X3035
Managed Healthcare
Business Summary
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Diagnostic Clinical Services
100.0
%
| 41 | 100.0 % | 32 | 100.0 % | -22.94% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 41 | 100.0 % | 32 | 100.0 % | -22.94% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Thomas Burnell
CEO | Chief Executive Officer | 62 | 20-11-30 |
Director of Finance/CFO | 32 | 19-05-31 | |
Nicole Massoll
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Jody Campbell
PRN | Corporate Officer/Principal | - | - |
Human Resources Officer | - | 21-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Vijay Aggarwal
BRD | Director/Board Member | 75 | 22-01-31 |
Joseph Keegan
BRD | Director/Board Member | 71 | 15-12-31 |
Stephen Sullivan
BRD | Director/Board Member | 77 | 04-08-31 |
Fortunato Rocca
BRD | Director/Board Member | 62 | 20-01-21 |
Thomas Burnell
CEO | Chief Executive Officer | 62 | 20-11-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 47,000 | 0 | 0 | 72.25 % |
Stock B | 1 | 4,407,492 | 3,184,448 ( 72.25 %) | 85,720 ( 1.945 %) |
Company contact information
Interpace Biosciences, Inc.
Waterview Plaza Suite 310
07054, Parsippany
+855 776 6419
http://www.interpacediagnostics.comSector
1st Jan change | Capi. | |
---|---|---|
-16.85% | 5.66B | |
+4.65% | 1.34B |